These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24006363)

  • 21. MiR-192-Mediated Positive Feedback Loop Controls the Robustness of Stress-Induced p53 Oscillations in Breast Cancer Cells.
    Moore R; Ooi HK; Kang T; Bleris L; Ma L
    PLoS Comput Biol; 2015 Dec; 11(12):e1004653. PubMed ID: 26642352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants.
    Waterman MJ; Waterman JL; Halazonetis TD
    Cancer Res; 1996 Jan; 56(1):158-63. PubMed ID: 8548757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells.
    Ishioka C; Shimodaira H; Englert C; Shimada A; Osada M; Jia LQ; Suzuki T; Gamo M; Kanamaru R
    Biochem Biophys Res Commun; 1997 Mar; 232(1):54-60. PubMed ID: 9125151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
    Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
    Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How p53 binds DNA as a tetramer.
    McLure KG; Lee PW
    EMBO J; 1998 Jun; 17(12):3342-50. PubMed ID: 9628871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation.
    Yakovlev VA; Bayden AS; Graves PR; Kellogg GE; Mikkelsen RB
    Biochemistry; 2010 Jun; 49(25):5331-9. PubMed ID: 20499882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain.
    Xu J; Zhou X; Wang J; Li Z; Kong X; Qian J; Hu Y; Fang JY
    Cell Rep; 2013 May; 3(5):1526-38. PubMed ID: 23684608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of tumor suppressor protein p53-dependent transcription by a tetramerization domain peptide via hetero-oligomerization.
    Wada J; Kamada R; Imagawa T; Chuman Y; Sakaguchi K
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2780-3. PubMed ID: 22429466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.
    Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4735-40. PubMed ID: 15781852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Explaining oscillations and variability in the p53-Mdm2 system.
    Proctor CJ; Gray DA
    BMC Syst Biol; 2008 Aug; 2():75. PubMed ID: 18706112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation.
    Erster S; Mihara M; Kim RH; Petrenko O; Moll UM
    Mol Cell Biol; 2004 Aug; 24(15):6728-41. PubMed ID: 15254240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.
    van Dieck J; Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
    J Biol Chem; 2009 May; 284(20):13804-13811. PubMed ID: 19297317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antioxidant function of the p53 tumor suppressor.
    Sablina AA; Budanov AV; Ilyinskaya GV; Agapova LS; Kravchenko JE; Chumakov PM
    Nat Med; 2005 Dec; 11(12):1306-13. PubMed ID: 16286925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical modelling of p53 basal dynamics and DNA damage response.
    Chong KH; Samarasinghe S; Kulasiri D
    Math Biosci; 2015 Jan; 259():27-42. PubMed ID: 25433195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain.
    Heering J; Jonker HR; Löhr F; Schwalbe H; Dötsch V
    Protein Sci; 2016 Feb; 25(2):410-22. PubMed ID: 26473758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-3-3 sigma positively regulates p53 and suppresses tumor growth.
    Yang HY; Wen YY; Chen CH; Lozano G; Lee MH
    Mol Cell Biol; 2003 Oct; 23(20):7096-107. PubMed ID: 14517281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization.
    Mateu MG; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3595-9. PubMed ID: 10097082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A theoretical model for p53 dynamics: identifying optimal therapeutic strategy for its activation and stabilization.
    Kim DH; Rho K; Kim S
    Cell Cycle; 2009 Nov; 8(22):3707-16. PubMed ID: 19844169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tetramerization domain of p53 is required for efficient BAK oligomerization.
    Pietsch EC; Leu JI; Frank A; Dumont P; George DL; Murphy ME
    Cancer Biol Ther; 2007 Oct; 6(10):1576-83. PubMed ID: 17895645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.